Clinical trial
Clinical PET Imaging Evaluation of 68Ga-NB381 Probe in Multiple Myeloma
NCT06385652 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical PET Imaging Evaluation of 68Ga-NB381 Probe in Multiple Myeloma
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.